MA59667B1 - Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons - Google Patents

Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons

Info

Publication number
MA59667B1
MA59667B1 MA59667A MA59667A MA59667B1 MA 59667 B1 MA59667 B1 MA 59667B1 MA 59667 A MA59667 A MA 59667A MA 59667 A MA59667 A MA 59667A MA 59667 B1 MA59667 B1 MA 59667B1
Authority
MA
Morocco
Prior art keywords
essential oil
bronchi
lungs
throat
act
Prior art date
Application number
MA59667A
Other languages
English (en)
Other versions
MA59667A1 (fr
Inventor
Ouaritini Nabil Bouziane
Hassani Nabila El
Abla Sakout
Original Assignee
Az-Pharma Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Az-Pharma Laboratoires filed Critical Az-Pharma Laboratoires
Priority to MA59667A priority Critical patent/MA59667B1/fr
Priority to PCT/MA2024/000005 priority patent/WO2024191278A1/fr
Publication of MA59667A1 publication Critical patent/MA59667A1/fr
Publication of MA59667B1 publication Critical patent/MA59667B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/723Xanthans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Insects & Arthropods (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une nouvelle composition dun complément alimentaire à base de plantes, plus particulièrement linvention concerne le domaine des compléments alimentaires à base de plantes efficace contre la toux et linflammation bronchique, elle est spécialement formulée pour agir au niveau de la gorge, les bronches et les poumons pour aider à soulager linflammation et la congestion tout en maîtrisant la toux et facilitant la respiration. La composition du complément alimentaire comprend en pourcentage de poids 15 totale : 33,38 % deau purifiée , 34% de sorbitol ,31,50 % de glycérine , 0,50 % de propolis, 0,20 % de gomme xanthane , 0,10 % de benzoate de sodium , 0,10% de potassium sorbate, 0,09% de lhuile essentielle deucalyptus globulus, 0,07% de lhuile essentielle de thymus vulgaris , 0,03 % de lhuile essentielle deugenia caryophyllus, 0,03 % de lhuile essentielle de Mentha Piperita offrant en synergie une efficacité contre la toux et linflammation bronchique, spécialement formulé pour agir au niveau de la gorge, les bronches et les poumons pour aider à soulager linflammation et la congestion tout en maîtrisant la toux et facilitant la respiration.
MA59667A 2023-03-10 2023-03-10 Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons MA59667B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA59667A MA59667B1 (fr) 2023-03-10 2023-03-10 Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons
PCT/MA2024/000005 WO2024191278A1 (fr) 2023-03-10 2024-03-11 Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA59667A MA59667B1 (fr) 2023-03-10 2023-03-10 Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons

Publications (2)

Publication Number Publication Date
MA59667A1 MA59667A1 (fr) 2024-09-30
MA59667B1 true MA59667B1 (fr) 2024-12-31

Family

ID=90458263

Family Applications (1)

Application Number Title Priority Date Filing Date
MA59667A MA59667B1 (fr) 2023-03-10 2023-03-10 Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons

Country Status (2)

Country Link
MA (1) MA59667B1 (fr)
WO (1) WO2024191278A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1003537A1 (fr) * 1997-08-11 2000-05-31 André Pierre Morice Composition comprenant de la propolis et au moins une huile essentielle
WO2002062362A2 (fr) * 2001-02-06 2002-08-15 Theodore Cherbuliez Composition antivirale et antibacterienne comprenant de la propolis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
JP4216013B2 (ja) 2002-07-26 2009-01-28 株式会社ロッテ 抗インフルエンザウイルス剤
US20090053319A1 (en) 2007-08-21 2009-02-26 Wayne Jeffrey Perry Sore Throat Relief Composition And Method of Producing Same
US10111912B2 (en) * 2012-10-18 2018-10-30 Montero Gida Sanayi Ve Ticaret A.S. Herbal formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1003537A1 (fr) * 1997-08-11 2000-05-31 André Pierre Morice Composition comprenant de la propolis et au moins une huile essentielle
WO2002062362A2 (fr) * 2001-02-06 2002-08-15 Theodore Cherbuliez Composition antivirale et antibacterienne comprenant de la propolis

Also Published As

Publication number Publication date
WO2024191278A1 (fr) 2024-09-19
MA59667A1 (fr) 2024-09-30

Similar Documents

Publication Publication Date Title
CN107095929A (zh) 一种治疗和预防牙齿松动的中草药配方
JP2004524304A5 (fr)
PE20081788A1 (es) Combinaciones farmaceuticas
BR112013008771B1 (pt) Formulações para o tratamento de distúrbios do trato respiratório superior
MA59667B1 (fr) Complément alimentaire formulé pour agir au niveau de la gorge, les bronches et les poumons
Yu et al. Natural essential oils efficacious in internal organs fibrosis treatment: Mechanisms of action and application perspectives
Boyd et al. Nutmeg oil and camphene as inhaled expectorants
CN111214571A (zh) 一种治疗鼻炎的外用中药药膏
HRP20080009T3 (en) Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity
Shrivastava Immunity boosters: Solutions from nature–Herbs and spices
BRPI0614079A2 (pt) marrubiin e composição para a diminuição do ressono, embalagem e método
CN103083404A (zh) 鼻腔保护剂
Khalili et al. Effects of alcoholic extract of Zingiber officinalis rhizome on acute and chronic inflammation and pain in rats
PL431580A1 (pl) Preparat do regeneracji i nawilżania błony śluzowej nosa
RU2208447C2 (ru) Масляный бальзам противовоспалительного, обезболивающего, иммуностимулирующего действия (варианты)
PH22022050157U3 (en) Compositions comprising antidesma bunius extract
CN110893217A (zh) 一种具有戒烟保健功能的中药香液及制备方法
WO2025209614A8 (fr) Pulvérisation orale virucide de propolis
CN103690641A (zh) 一种治疗鼻炎中药
Turner A Discourse Concerning Gleets: Their Cause and Cure: with a Prefatory Account of Professor Boerhaave's New Comments on the Venereal Disease...
CN106138482A (zh) 一种治疗鼻黏膜炎症的草药配方
IT202200002513U1 (it) Composizione di un integratore alimentare in gel per coadiuvare il transito intestinale
WO2022154772A1 (fr) Agent antiviral utilisé dans des infections virales du tractus respiratoire supérieur et composition pharmaceutique le comprenant
Nandi et al. PROTECTIVE ROLE OF MEDICINAL PLANTS ON NICOTINE-INDUCED TISSUE TOXICITY
Sahu et al. Potential Herbs for Upper Respiratory Illness and their Current Utility